03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Avastin 100mg* : | |
Type | Medicine Non Marketed |
Originator | Biotech (Avastin 100mg) |
Agent | Omnipharma |
Distributor | Omnipharma |
Laboratory | Roche |
Responsible Party | Genentech Inc |
Origin | U.S.A. |
Manufacturer | Genentech Inc |
Origin | U.S.A. |
ATC | L01XC07 |
Revision Date | 01/01/2015 |
Avastin 100mg* :
Avastin 100mg* :
Avastin 100mg* :
Avastin 100mg* :
Avastin 100mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Avastin 100mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Abscess | Common |
Anaemia | Common |
Anorexia | Very Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
Asthenia | Very Common |
Back pain | Common |
Cellulitis | Common |
Cephalea | Very Common |
Cerebrovascular accident | Common |
Congestive heart failure | Common |
Constipation | Very Common |
Deep vein thrombosis | Common |
Dehydration | Common |
Dermatitis exfoliative | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Dry mouth (Xerostomia) | Very Common |
Dysarthria | Very Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspnoea (dyspnea) | Very Common |
Epistaxis (Nasal bleeding) | Very Common |
Eye disorder | Very Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Very Common |
Gastrointestinal disorders | Common |
Haemorrhage | Common |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Common |
Hypertension | Very Common |
Hypoxia | Common |
Ileus | Common |
Infection | Common |
Intestinal obstruction | Common |
Intestinal perforation | Common |
Lacrimation increased (Epiphora) | Very Common |
Lethargy | Common |
Leucopenia (Leukopenia) | Very Common |
Lymphopenia | Common |
Mucosal inflammation | Very Common |
Muscle weakness | Common |
Myalgia | Common |
Nausea | Very Common |
Neutropenia | Very Common |
Ovarian insufficiency | Very Common |
Pain | Very Common |
Pelvic pain | Common |
Peripheral sensory neuropathy | Very Common |
Proctalgia | Common |
Proteinuria | Very Common |
Pulmonary embolism | Common |
Pyrexia | Very Common |
Recto-vaginal fistulae | Common |
Rectorrhagia | Very Common |
Rhinitis | Very Common |
Septicemia | Common |
Somnolence | Common |
Stomatitis | Very Common |
Supraventricular tachyarrhythmia | Common |
Syncope | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Thromboembolism arterial | Common |
Tumour necrosis | Very Common |
Urinary tract infection | Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Very Common |
Avastin 100mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Avastin 100mg* MoH 3946 :
Form | Concentrate for solution for infusion |
Packaging | Bottle |
Package Size | 1x4ml |
Strength | 100mg |
Storage Condition | 2-8°C protect from light |
NSSF | ✘ |
Quarantine | ✔ |
Reg. Number | 194456/05 |
Submission date | 01/01/2005 |
Registration Year | 2005 |
Archived Date | 2018 |
Price Comparison
● Country: | Abu Dhabi | |
● Package Size: | 1x4ml | |
● Public Price: | 2767.5 AED | ( 66,865,567.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2767,5 AED | ( 66,853,487.00 LBP ) |
● Pharmacy Price: | 2357.82 AED | ( 56967289.02 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 4ml Vial | |
● Public Price: | 2767.5 AED | ( 66,865,567.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2767,5 AED | ( 66,853,487.00 LBP ) |
● Pharmacy Price: | 2357.82 AED | ( 56967289.02 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 1x4ml | |
● Public Price: | 479.39 EUR | ( 46,441,385.64 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 479,39 EUR | ( 46,403,604.00 LBP ) |
● Exfactory Price: | 290.47 EUR | |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Germany | |
● Package Size: | 1 | |
● Public Price: | 468.52 EUR | ( 45,388,343.52 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 468,52 EUR | ( 45,337,968.00 LBP ) |
● Pricing Date: | 24/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 1x4ml | |
● Public Price: | 1812 QAR | ( 44,499,096.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1812 QAR | ( 44,499,096.00 LBP ) |
● Pharmacy Price: | 1488.562363158 QAR | ( 36556114.514434 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Finland | |
● Package Size: | 1x4ml | |
● Public Price: | 459.17 EUR | ( 44,482,552.92 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 459,17 EUR | ( 44,466,084.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 1x4ml | |
● Public Price: | 190.8 OMR | ( 44,024,047.20 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 190,8 OMR | ( 43,839,460.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 1x4ml | |
● Public Price: | 410.65 CHF | ( 42,469,423.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 410,65 CHF | ( 42,402,200.00 LBP ) |
● Exfactory Price: | 343.42 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 1x4ml | |
● Public Price: | 62644 ISK | ( 40,405,380.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 62644 ISK | ( 40,405,380.00 LBP ) |
● Pharmacy Price: | 47003 ISK | ( 30316935 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 1x4ml | |
● Public Price: | 316.49 JOD | ( 39,631,194.29 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 316,49 JOD | ( 39,569,836.00 LBP ) |
● Pharmacy Price: | 304.32 JOD | ( 38107254.72 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 1x4ml | |
● Public Price: | 408.32 EUR | ( 39,556,408.32 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 408,32 EUR | ( 39,525,408.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 4ml | |
● Public Price: | 397.05 EUR | ( 38,464,615.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 397,05 EUR | ( 38,459,772.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 1x4ml | |
● Public Price: | 161.07 BHD | ( 38,291,815.38 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 161,07 BHD | ( 38,275,174.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 4ml | |
● Public Price: | 1550.85 SAR | ( 36,662,094.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1550,85 SAR | ( 36,642,000.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Denmark | |
● Package Size: | 1x4ml | |
● Public Price: | 2819 DKK | ( 36,579,344.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2819 DKK | ( 36,579,344.00 LBP ) |
● Pharmacy Price: | 2090.82 DKK | ( 27130480.32 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 1x4ml | |
● Public Price: | 8856.59 CZK | ( 33,823,317.21 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 8856,59 CZK | ( 33,821,064.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 1x4ml | |
● Public Price: | 340.55 EUR | ( 32,991,121.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 340,55 EUR | ( 32,937,840.00 LBP ) |
● Pharmacy Price: | 333.55 EUR | ( 32312989.8 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 1x4ml | |
● Public Price: | 321 EUR | ( 31,097,196.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 321 EUR | ( 31,097,196.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 1x4ml | |
● Public Price: | 3598.8 NOK | ( 29,164,675.20 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 3598,8 NOK | ( 29,158,192.00 LBP ) |
● Pharmacy Price: | 2780.49 NOK | ( 22533090.96 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 1x4ml | |
● Public Price: | 284.25 EUR | ( 27,537,003.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 284,25 EUR | ( 27,512,784.00 LBP ) |
● Exfactory Price: | 235.9 EUR | |
● Pharmacy Price: | 239.43 EUR | ( 23195020.68 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1x4ml | |
● Public Price: | 242.66 GBP | ( 27,578,066.34 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 242,66 GBP | ( 27,503,058.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Turkey | |
● Package Size: | 1x4ml | |
● Public Price: | 1131.71 TRY | ( 3,032,982.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1131,71 TRY | ( 3,031,080.00 LBP ) |
● Medica Comments: | ALTUZAN=Avastin | |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | France |
● Package Size: | 1x4ml |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File